⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Mirae Asset Healthcare Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | — | HDFC MF |
| Category | Equity - Sectoral Fund - Pharma & Health Care | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹51.66 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★★ | ★★★★★ |
| Benchmark | BSE Health Care - TRI | BSE Health Care - TRI |
| Fund Manager | Vrijesh Kasera | Nikhil Mathur |
| Inception | 02 Jul 2018 | 04 Oct 2023 |
| Returns | ||
| 1Y | 16.88% | 22.64% |
| 3Y | 23.50% | 30.41% |
| 5Y | 16.37% | — |
| Since Inception | 21.63% | 29.15% |
| Risk | ||
| 13.98 | 14.07 | |
| 0.95 | 0.59 | |
| 1.10 | 1.59 | |
| 1.99 | 21.67 | |
| 2.43 | 3.48 | |
| -9.48% | -9.23% | |
| Costs | ||
| Expense Ratio | 0.62% | 1.03% |
| Exit Load | 1% on or before 30D, NIL after 30D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹99 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Mirae Asset H…53%
HDFC MF53%
47.4%Only 47.4% of holdings by weight are common between Mirae Asset Healthcare Fund - Growth - Direct Plan and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingMirae Asset Healthcare Fund - Growth - Direct PlanHDFC MF
Divi's Laboratories Ltd.9.79%9.39%
Sun Pharmaceutical Industries Ltd.10.15%8.28%
Alkem Laboratories Ltd.3.76%4.64%
Apollo Hospitals Enterprise Ltd.5.62%3.69%
Torrent Pharmaceuticals Ltd.6.80%3.65%
Aster DM Quality Care Ltd.3.32%3.56%
Dr. Reddy's Laboratories Ltd.4.84%3.19%
Ipca Laboratories Ltd.3.39%2.98%
Cipla Ltd.2.63%4.15%
Max Healthcare Institute Ltd.2.35%3.61%
Krishna Institute of Medical Sciences Ltd3.39%2.10%
Glenmark Pharmaceuticals Ltd.4.78%2.09%
Category context: Equity vs Equity. Open the full Screener →